An in vivo proton neurospectroscopy study of cerebral oxidative stress in myalgic encephalomyelitis (chronic fatigue syndrome).
Puri, B K, Agour, M, Gunatilake, K D R et al. · Prostaglandins, leukotrienes, and essential fatty acids · 2009 · DOI
Quick Summary
This study used brain imaging to measure levels of a protective molecule called glutathione in the brains of people with ME/CFS. Researchers had expected glutathione levels to be lower in ME/CFS patients because it was reduced in their blood, but surprisingly, the brain levels were similar between patients and healthy controls. The study found no evidence that taking glutathione supplements would help with ME/CFS brain-related symptoms.
Why It Matters
This was the first direct measurement of brain glutathione in ME/CFS patients, testing whether oxidative stress—a proposed mechanism in the disease—manifests as depleted antioxidant defenses in the brain. The results challenge the rationale for glutathione supplementation as a treatment strategy and highlight that peripheral findings in ME/CFS may not reliably reflect central nervous system pathology.
Observed Findings
Mean cerebral GSH in ME/CFS patients was 2.703 (SD 2.311) mmol/kg
Mean cerebral GSH in healthy controls was 5.191 (SD 8.984) mmol/kg
No statistically significant difference was found between patient and control groups (p=NS)
Control group showed substantially higher variance in GSH measurements than the patient group
Measurements were obtained from single 20×20×20mm³ voxels using point-resolved spectroscopy
Inferred Conclusions
Cerebral glutathione is not reduced in ME/CFS patients compared to healthy controls
Peripheral blood GSH reductions in ME/CFS are not reflected in brain tissue
Glutathione supplementation may not improve brain-related symptoms of ME/CFS based on current evidence
Remaining Questions
Do other antioxidant defense systems (superoxide dismutase, catalase, peroxiredoxins) show abnormalities in ME/CFS brain tissue?
Do GSH levels differ across specific brain regions rather than in a single voxel location?
Are there temporal changes in brain GSH levels at different stages of illness?
What This Study Does Not Prove
This study does not prove that oxidative stress is absent in ME/CFS—it only shows that GSH levels specifically are not reduced. It also does not establish that glutathione supplementation has no benefit, only that restoring brain GSH levels may not be its mechanism. The cross-sectional design cannot determine whether GSH abnormalities exist at other brain regions, or change over disease course.
Tags
Symptom:Fatigue
Biomarker:MetabolomicsNeuroimaging
Method Flag:Weak Case DefinitionSmall SampleExploratory Only